Creating a standardised post-discharge medication reconciliation checklist

Discharge is a vulnerable point in a patient’s medicine journey. A person may leave hospital with new prescriptions, discontinued treatments, altered doses and advice delivered quickly amid pain, fatigue or anxiety. Community pharmacists are often the first health professionals available to identify discrepancies once the patient returns home.

A standardised checklist for pharmacist conduction of medication reconciliation post-discharge gives this work a reliable sequence. It supports clinical judgement rather than replacing it, helping pharmacists compare the hospital plan with the patient’s actual medicines, resolve discrepancies and communicate changes to the wider care team.

Why post-discharge reconciliation needs structure

Medication reconciliation is more than checking whether a discharge prescription has been dispensed. It involves creating the most accurate possible list of medicines before admission, comparing it with the discharge regimen, identifying intentional and unintentional changes, and confirming that the patient understands what to take. The process should include prescription medicines, over-the-counter products, complementary medicines, inhalers, insulin, topical treatments and medicines used only occasionally.

Transitions from Australian hospitals can be particularly complex. A patient may have prescriptions from a public hospital, an existing general practitioner, a private specialist and a community pharmacy. PBS listings may not immediately explain why a medicine changed, while a discharge summary can arrive later than the patient. In regional and remote communities, limited access to prescribers and long travel distances can make a prompt pharmacist review even more important.

The checklist should also account for practical factors. A patient using a Webster-pak or another dose administration aid may need a pack rebuilt before the next dose. Someone discharged after surgery may have a short course of analgesia or antibiotics alongside long-term medicines. An older person returning to a residential aged-care facility may have facility-specific administration records that need reconciliation with the hospital documentation.

Define the scope and assign responsibility

The pharmacy should define when the service begins, who is eligible and what information must be collected. A practical trigger could include discharge after an unplanned admission, a medicine-related admission, a change to five or more regular medicines, a new high-risk medicine, or a patient with limited health literacy or reduced support at home. The service may be initiated when the patient presents with a discharge prescription, when a family member calls, or when the hospital sends information electronically.

Responsibility must be clear. The pharmacist conducting the review should be able to access the discharge summary, medication administration record when available, dispensing history and relevant clinical notes. Pharmacy technicians can help gather documents and contact details, but the pharmacist should assess clinical discrepancies, provide counselling and decide when escalation is required.

A written workflow can prevent the task from becoming dependent on one experienced staff member. It should state the expected timeframe, such as review within 48 to 72 hours of discharge, and explain how urgent issues are handled. The pharmacist should record attempts to contact the patient, prescriber or hospital team, including unanswered calls and unresolved questions.

In Australia, My Health Record may support information gathering, but it should not be treated as a complete or automatically current medicine list. Consent, document availability and the timing of uploads vary. The patient, carer, residential facility and dispensing history remain essential sources of information.

Build the checklist around a repeatable workflow

A useful checklist follows the patient’s journey rather than the pharmacy’s internal filing system. It begins with identity and risk screening, then moves through information collection, comparison, clinical review, patient communication, documentation and follow-up. Each step should include a space for action taken and the person responsible.

The first page can capture:

  • Patient identifiers, date of birth, address and preferred contact method
  • Date of hospital discharge, admitting diagnosis and treating facility
  • Contact details for the GP, specialists, hospital ward and carer
  • Allergies, adverse drug reactions and previous medicine-related problems
  • Current medicines supplied by the pharmacy, including dose administration aids
  • New, ceased, withheld, substituted or dose-adjusted medicines
  • High-risk treatments requiring priority review
  • Follow-up appointments, pathology requirements and monitoring instructions

The next stage should compare at least three medicine lists: the pre-admission list, the discharge list and the patient’s actual medicines at home. The pharmacist should mark each medicine as continued, changed, stopped, newly commenced, duplicated, omitted or uncertain. “Uncertain” should be treated as an active problem requiring clarification rather than as permission to continue or stop treatment.

The workflow should include a short patient interview. Patients often reveal discrepancies that do not appear in formal records, such as taking half a tablet because the full dose caused dizziness, using an old inhaler, sharing a family member’s medicine, or stopping a treatment because of cost. Australia’s PBS safety net may reduce some financial barriers, but copayments, transport costs and medicine shortages can still affect adherence.

Checklist stage Key pharmacist action Evidence to record Escalation trigger
Confirm identity and risk Verify the patient, discharge date, allergies and vulnerability factors Patient identifiers and risk flags Unclear identity, allergy conflict or high clinical risk
Collect medicine information Review discharge documents, dispensing history, My Health Record and patient-held medicines Sources checked and dates of documents Conflicting or missing medicine lists
Compare regimens Classify each medicine as continued, changed, ceased, new or uncertain Reconciled list with reasons for changes Duplicate therapy, omission or unexplained dose change
Speak with the patient or carer Confirm actual use, understanding, access and ability to manage the regimen Patient-reported use and education provided Confusion, inability to administer or suspected adverse effect
Contact the prescriber or hospital Resolve clinically significant discrepancies Name, time, advice and agreed action High-risk medicine, urgent symptom or no safe interim plan
Implement and follow up Update records, arrange supply and check progress Updated profile and follow-up date Missed doses, deterioration or unresolved discrepancy

Verify clinical changes with the patient

The medicine list should be discussed in plain language, preferably using the actual boxes, blister packs or dose administration aids. Ask the patient to explain what each medicine is for, when it is taken and what changed after discharge. This teach-back approach can identify misunderstandings without making the patient feel tested.

High-risk medicines deserve a deliberate check. These may include anticoagulants, insulin, opioids, hypoglycaemic medicines, immunosuppressants, anticonvulsants, methotrexate and medicines with a narrow therapeutic index. The pharmacist should confirm dose, indication, duration, monitoring, administration technique and warning signs. A patient discharged on warfarin, for example, may need confirmation of the next INR test and the person responsible for reviewing the result.

The checklist should prompt consideration of function and cognition. Can the patient open packaging, read labels, measure a liquid, use an inhaler or remember a variable dose? Is a family member administering medicines? Does the person need an interpreter, large-print labels or a staged supply? For people with autism or intellectual disability, sensory preferences, communication style and routines can affect medicine use. Practical approaches to medication management autism can help pharmacists make the reconciliation conversation more individualised.

A medicine may be clinically appropriate yet unworkable at home. The pharmacist should check whether the medicine is available through the local pharmacy, whether the dosage form is suitable and whether the patient can afford or collect it. If a product is unavailable, the prescriber may need to approve an alternative rather than leaving the patient without treatment.

Document decisions and communicate clearly

Every discrepancy should be documented with its outcome. A useful record states the medicine involved, the difference identified, the likely cause, the person contacted, the advice received and the final plan. “Resolved” is insufficient without noting how it was resolved. This record protects continuity when another pharmacist, GP or hospital clinician becomes involved.

Communication should be proportional to risk. A minor timing clarification may be recorded in the pharmacy profile and explained to the patient. A potentially harmful duplication, omitted anticoagulant or incorrect insulin dose requires direct contact with the prescriber or hospital team. When the patient is unstable or reports severe symptoms, the pharmacist should use the appropriate urgent medical pathway rather than relying on routine faxing or a future appointment.

Send the reconciled medicine list to the GP and, where relevant, the residential aged-care service, specialist, home-care provider or carer. Use secure channels and follow privacy requirements. The list should clearly distinguish current medicines from those stopped at discharge, include the source and date, and identify pending actions such as pathology or review appointments.

The patient should leave the interaction with an understandable action plan. This may include a printed list, updated labels, a staged supply, a new dose administration aid or a reminder to bring all medicines to the next appointment. Pharmacists should avoid assuming that a discharge label has been read or understood, especially when several medicines have similar names or packaging.

Link reconciliation with adherence and follow-up

Reconciliation is most effective when it leads to an observable follow-up action. Contact the patient after an agreed interval, often within one to two weeks, to confirm that medicines were obtained and taken as planned. Earlier contact may be needed for high-risk treatments, patients living alone, people with cognitive impairment or anyone who experienced a medicine-related problem during admission.

A synchronised refill date can reduce missed supplies once the regimen is stable. Evidence and practical experience around medication synchronisation programmes are relevant when coordinating chronic medicines after a disruptive hospital stay. The pharmacist should first ensure that synchronisation does not cause premature supply, confusion about doses or problems with PBS entitlement.

The follow-up can ask about adverse effects, symptom control, access, medicine-taking routines and changes made by another clinician. It is also an opportunity to check whether the patient attended a GP appointment or completed required pathology. In metropolitan areas such as Melbourne, Sydney and Brisbane, communication with multiple services may be possible by secure messaging or telephone. In smaller towns, the community pharmacist may need to coordinate more actively because there may be fewer local prescribers and longer waits for appointments.

Services such as Home Medicines Review may be appropriate when the patient has complex therapy, repeated admissions, adherence concerns or significant discrepancies. A pharmacist should explain the purpose of the review and coordinate it with the GP rather than presenting it as a substitute for immediate reconciliation after discharge.

Measure performance and improve the service

A checklist should be audited for usefulness, not simply completion. The pharmacy can track how many eligible patients receive a review, the time from discharge to contact, the number and type of discrepancies identified, the proportion resolved within a defined period, and the number of follow-up contacts completed. Patient-reported understanding and medicine access are valuable measures alongside clinical indicators.

Review a sample of records each month to identify recurring weaknesses. The findings may show that discharge summaries often omit stop dates, that patients do not know which GP is managing a medicine, or that dose administration aids are being updated too late. These patterns can support constructive communication with local hospitals, GP practices and aged-care services.

The checklist should be tested with the people who use it. Pharmacists need a format that fits dispensing software and does not duplicate information unnecessarily. Patients benefit from clear language and a manageable medicine list. A rural pharmacy may require a different escalation directory from a large Sydney practice, while a pharmacy supporting several aged-care facilities may need fields for facility charts and after-hours contacts.

A formal review every six or twelve months keeps the process current. Include changes to electronic health records, local referral pathways, medicine shortages, privacy procedures and staff roles. Training should use realistic cases, such as a patient discharged from a Perth hospital with an altered insulin regimen or an older person in regional New South Wales whose discharge medicines conflict with a dose administration aid.

A consistent post-discharge medication reconciliation process turns scattered information into a safer shared plan. Pharmacies can begin with a concise checklist, define escalation rules and refine the workflow through audits and patient feedback. The result is a practical service that supports continuity between hospital, home, community pharmacy and primary care.

Use the checklist at the next eligible discharge, document every unresolved discrepancy and set a follow-up date before closing the record. Small, reliable actions at this transition can prevent medicine errors, strengthen collaboration and give patients greater confidence in managing treatment at home.